Диссертация (1139747), страница 27
Текст из файла (страница 27)
// J Rheumatol. 2007 Dec;34(12):2481-5.Epub 2007 Nov 15132. Wong SC, Dobie R, Altowati MA, Werther GA, Farquharson C, AhmedSF. Growth and the Growth Hormone-Insulin Like Growth Factor 1 Axis inChildren With Chronic Inflammation: Current Evidence, Gaps in Knowledge,and Future Directions. //Endocr Rev. 2016 Feb;37(1):62-110. doi:10.1210/er.2015-1026.
Epub 2015 Dec 31154133. Wong SC, MacRae VE, Gracie JA, McInnes IB, Galea P, GardnerMedwin J, Ahmed SF. Inflammatory cytokines in juvenile idiopathic arthritis:effects on physical growth and the insulin-like-growth factor axis. // GrowthHorm IGF Res. 2008 Oct;18(5):369-78.
doi: 10.1016/j.ghir.2008.01.006.Epub 2008 Apr 2134. Yokota S, Imagawa T, Mori M, Miyamae T, Takei S, Iwata N,Umebayashi H, Murata T, Miyoshi M, Tomiita M, Nishimoto N, KishimotoT. Longterm safety and effectiveness of the anti-interleukin 6 receptormonoclonal antibody tocilizumab in patients with systemic juvenile idiopathicarthritis in Japan. // J Rheumatol.
2014 Apr;41(4):759-67. doi:10.3899/jrheum.130690. Epub 2014 Mar 15135. Yokota S. Interleukin-6 as a pathogenic factor of systemic-onsetjuvenile idiopathic arthritis. // Nihon Rinsho Meneki Gakkai Kaishi. 2008Apr;31(2):99-103.136. Yokota S., Kikuchi M, Nozawa T, Kanetaka T, Sato T, Yamazaki K,Sakurai N, Hara R, Mori M. Pathogenesis of systemic inflammatory diseasesin childhood: "Lessons from clinical trials of anti-cytokine monoclonalantibodies for Kawasaki disease, systemic onset juvenile idiopathic arthritis,and cryopyrin-associated periodic fever syndrome".Mod Rheumatol. 2015Jan;25(1):1-10.
doi: 10.3109/14397595.2014.902747. Epub 2014 May 20.137. Yokota S., Miyamae T, Imagawa T, Iwata N, Katakura S, Mori M.Inflammatory cytokines and systemic-onset juvenile idiopathic arthritis. //Mod Rheumatol. 2004;14(1):12-7138. Yokota S., Tanaka T, Kishimoto T. Efficacy, safety and tolerability oftocilizumab in patients with systemic juvenile idiopathic arthritis.// Ther AdvMusculoskeletDis.2012Dec;4(6):387-97.doi:10.1177/1759720X12455960.139. Zhang X, Morcos PN, Saito T, Terao K. Clinical pharmacologyof tocilizumab for the treatment of systemic juvenile idiopathic arthritis.
//Expert Rev Clin Pharmacol. 2013 Mar;6(2):123-37. doi: 10.1586/ecp.13.1.155.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
